Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for secondary prevention of coronary heart disease
NCT00327691Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 1998
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 4 trial of atorvastatin in coronary heart disease (CHD), cardiovascular disease (CVD), cerebrovascular accident (CVA), sponsored by Pfizer. Started Apr 1998; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronary heart disease (CHD)cardiovascular disease (CVD)cerebrovascular accident (CVA)
Beyond the preview
Go deeper on NCT00327691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327691.